Tenor Capital Management’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

Tenor Capital Management’s Portfolio EBACW Stock Details EBACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-33,333	Closed	-$9.93K	–	594
2022 Q4	$9.93K	Hold	33,333	–	–	﹤0.01%	428
2022 Q3	$3K	Hold	33,333	–	–	﹤0.01%	745
2022 Q2	$5K	Hold	33,333	–	–	﹤0.01%	794
2022 Q1	$7K	Hold	33,333	–	–	﹤0.01%	878
2021 Q4	$20K	Hold	33,333	–	–	﹤0.01%	778
2021 Q3	$21K	Hold	33,333	–	–	﹤0.01%	728
2021 Q2	$32K	Buy	+33,333	New	+$31K	﹤0.01%	738

Tenor Capital Management's EBACW Position: Q1 2023 in Review

Tenor Capital Management sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q1 2023, closing a stake of 33,333 shares — an estimated $9.93K sold.

Tenor Capital Management first reported a position in EBACW in Q2 2021 and held it in 7 quarters. The position peaked at $32K in Q2 2021. 0 funds tracked by Wall St. Rank hold EBACW as of Q1 2023.

Tenor Capital Management reported no remaining European Biotech Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
Tenor Capital Management sold 33,333 European Biotech Acquisition Corp. Warrant shares in Q1 2023, an estimated $9.93K.
Tenor Capital Management first reported a position in European Biotech Acquisition Corp. Warrant in Q2 2021 and held it in 7 quarters.
Tenor Capital Management's European Biotech Acquisition Corp. Warrant position peaked at $32K in Q2 2021.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q1 2023.

Based on Tenor Capital Management's 13F filing for Q1 2023, filed 15 May 2023.